Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 181 results found. Search for [ Daiichi ]

Results 1 to 21 of 181
www.businesstoday.in
February 19, 2018
The corporate affairs ministry has been looking into the affairs of Fortis Healthcare and Religare Enterprises after recent reports that financial irregularities have emerged at the two companies


www.businesstoday.in
February 14, 2018



www.businesstoday.in
New Delhi, February 13, 2018
Fortis says that apart from paying Rs 65.98 lakh fine to stock exchanges for \"non-submission of un-audited financial results\", the reports emerging in the media had \"enhanced the scope of limited review audit by the statutory auditors\".


www.businesstoday.in
New Delhi, February 10, 2018
Fortis Healthcare was issued notices by the stock exchanges yesterday following a media report claiming that the company's promoters, the Singh bothers, took at least Rs 500 crore without board approval about a year ago.


www.businesstoday.in
New Delhi, February 9, 2018
The duo quit as directors from the company's board on Thursday. The company issued a release saying the resignation is \"intended to free the organisation from any encumbrances that may be linked to the promoters in light of the recent HC judgement.\"


www.businesstoday.in
February 9, 2018
Days after the Delhi High Court verdict dealt a body blow to Fortis Healthcare promoters - Malvinder Mohan Singh and Shivinder Mohan Singh - by upholding the Rs 3,500 crore arbitral award in favour of Daiichi Sankyo, the duo have quit as directors from the company's board


www.businesstoday.in
February 9, 2018



www.businesstoday.in
February 9, 2018
At 12:29 pm, the stock was trading 12.09% or 15.25 points higher at 141.35 level in an otherwise falling market. The stock hit an intra day high of 157.05 level and a low of 123.10 level. It is down 11.53% since the beginning of this year. On  an yearly basis, the stock has fallen 28.71% on BSE.


www.businesstoday.in
February 8, 2018



www.businesstoday.in
New Delhi, February 6, 2018
With the Delhi High Court's verdict, Daiichi Sankyo has scored a victory against former Ranbaxy promoters. But it won't end there.


www.businesstoday.in
January 31, 2018



www.businesstoday.in
New Delhi, February 8, 2018
Fortis Healthcare promoters Malvinder Mohan Singh and Shivinder Mohan Singh, also called Singh Brothers, on Thursday resigned as directors from the company's board days after the Delhi High Court order upheld the Rs 3,500 crore arbitral award in favour of Daiichi Sankyo.


www.businesstoday.in
January 30, 2018



www.businesstoday.in
Delhi, January 21, 2017



www.businesstoday.in
New Delhi, January 20, 2017
Abbott, the largest drug company operating in India in terms of domestic market share, following the acquisition of Piramal Healthcare's formulation division in 2010, is setting up an Innovation and Design Centre in Mumbai, which will take off next year.


www.businesstoday.in
January 18, 2017
It is the season of change and worry. A new avowedly protectionist administration will be sworn in on 20 January, when Donald Trump takes oath as the 45th President of the United States.


www.businesstoday.in
New Delhi, January 18, 2017
Its misadventure in India had began in June 2008 with the acquisition of Ranbaxy in an over $4-billion deal (around Rs 20,000 crore then) with the promise of utilising Ranbaxy's resources to become a 'global pharma innovator'.


www.businesstoday.in
January 18, 2017
Delhi High Court is hearing a plea from Japanese drug major Daiichi Sankyo, to prevent the erstwhile promoters of Ranbaxy pharmaceuticals - brothers Malvinder Mohan Singh and Shivinder Mohan Singh - from diluting their stake in Fortis Healthcare.


www.businesstoday.in
Delhi, November 12, 2016
The development at Tata Sons raises questions about the role of board of directors in companies


www.businesstoday.in
Delhi, November 12, 2016
Some international arbitration cases that have gone against India highlight the uncertainty in the country's policy and regulatory framework.


PAGES 1 OF 10  12345